ChartRow logo
ASND
Ascendis Pharma A/S Ordinary ShareStock · Health Care
$246.29−$9.17 (-3.59%)as of market close, Aug 13, 2026
☾ After hours:$246.23+0.00%3:59 PM ET
CompareLLYUNHJNJABBVISRGTMO

ASND returns by year

Ascendis Pharma A/S Ordinary Share has returned +24.4% annually (CAGR) since 2016. Calendar-year, monthly and weekly total returns for Ascendis Pharma A/S Ordinary Share (ASND) below, through August 13, 2026 — the most recent year is year-to-date.

Annualized (CAGR)
+24.4%
2016–2026
Average year
+34.6%
10 full years
Best year
+122.1%
2019
Worst year
-19.3%
2021
Positive years
8/10
80% up

Ascendis Pharma A/S Ordinary Share returns by year (20162026)#

Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).

Ascendis Pharma A/S Ordinary Share annual returns by year
YearTotal return
2026YTD
+15.5%
2025
+54.9%
2024
+9.3%
2023
+3.1%
2022
-9.2%
2021
-19.3%
2020
+19.9%
2019
+122.1%
2018
+56.4%
2017
+97.9%
2016
+10.5%

Total return by period

-100%-50%+0%+50%+100%
'16'17'18'19'20'21'22'23'24'25'26

Methodology#

Returns are total returns (dividends reinvested), computed from ASND's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.

See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum

FAQ#

What is Ascendis Pharma A/S Ordinary Share's average annual return?
Since 2016, Ascendis Pharma A/S Ordinary Share (ASND) has returned about 24.4% a year (the compound annual growth rate) and an average calendar-year return of 34.6%.
What were Ascendis Pharma A/S Ordinary Share's best and worst years?
Over 2016–2026, the best year was 2019 (+122.1%) and the worst was 2021 (-19.3%).
How often is Ascendis Pharma A/S Ordinary Share up in a year?
8 of the 10 full years since 2016 were positive — about 80% of the time.